0001209191-14-013508.txt : 20140224
0001209191-14-013508.hdr.sgml : 20140224
20140224163029
ACCESSION NUMBER: 0001209191-14-013508
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140220
FILED AS OF DATE: 20140224
DATE AS OF CHANGE: 20140224
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SACHS BRUCE I
CENTRAL INDEX KEY: 0001197036
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 14637297
MAIL ADDRESS:
STREET 1: 130 WAVERLY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2014-02-20
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001197036
SACHS BRUCE I
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
1
0
0
0
Common Stock
2014-02-20
4
S
0
1300
82.51
D
36910
D
Common Stock
2014-02-20
4
S
0
3800
83.65
D
33110
D
Common Stock
2014-02-20
4
S
0
3200
84.13
D
29910
D
Transaction made pursuant to Mr. Sachs' company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $82.51 (range $82.00 to $82.99).
Mr. Sachs undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $83.65 (range $83.16 to $83.99).
Open market sales reported on this line occurred at a weighted average price of $84.13 (range $84.02 to $84.35).
Kenneth L. Horton, Attorney-In-Fact
2014-02-24